Evidence map›Paper›PMID 42240140›Full record

ArticleThe Journal of dermatology2026

Juvenile-Onset SAPHO Syndrome With Acne-Hidradenitis Suppurativa Successfully Treated With Infliximab and Methotrexate.

Keiko Manabe, Moe Tokunaga, Shoichi Nawachi, Yoshia Miyawaki, Takayuki Katsuyama, Yoshinori Matsumoto, Mitsuru Tsuge, Yoshio Kawakami, Shin Morizane

Abstract readLetter
In one paragraph

Article in The Journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Keiko ManabeDepartment of Dermatology, Takamatsu Red Cross Hospital, Takamatsu, Japan.ORCID https://orcid.org/0000-0002-8074-5787
Moe TokunagaDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.ORCID https://orcid.org/0009-0001-1180-4405
Shoichi NawachiDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.ORCID https://orcid.org/0009-0005-3199-1905
Yoshia MiyawakiDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.ORCID https://orcid.org/0000-0002-6981-3443
Takayuki KatsuyamaDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.ORCID https://orcid.org/0000-0002-7159-5537
Yoshinori MatsumotoDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.ORCID https://orcid.org/0000-0001-7047-2976
Mitsuru TsugeDepartment of Pediatrics, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.ORCID https://orcid.org/0000-0001-9010-4708
Yoshio KawakamiDepartment of Dermatology, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.ORCID https://orcid.org/0000-0001-5609-6118
Shin MorizaneDepartment of Dermatology, Okayama University Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.ORCID https://orcid.org/0000-0003-1374-065X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42240140
PMCPMC13435089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.